OptiBiotix Health (GB:OPTI) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
OptiBiotix Health’s recent study at Roehampton University shows that their product SlimBiome significantly reduces hunger and food cravings, promoting feelings of fullness, which may offer a natural and effective alternative to anti-obesity drugs. The study’s participants also experienced reductions in body fat and an improvement in mood, indicating a sustainable approach to weight management without the adverse effects commonly associated with anti-obesity medications. SlimBiome’s use in various food products could potentially tap into the burgeoning market for healthy weight management solutions.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.
